Ligand Reports Second Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Ligand Reports Second Quarter 2020 Financial Results

Ligand Pharma (LGND) Tops Q2 EPS by 24c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus

August 3, 2020 7:37 AM EDT

Ligand Pharma (NASDAQ: LGND) reported Q2 EPS of $1.00, $0.24 better than the analyst estimate of $0.76. Revenue for the quarter came in at $41.4 million versus the consensus estimate of $31.39 million.

Outstanding second quarter financial results and operating execution have laid the foundation for our strong outlook for the rest of 2020 and beyond. We... More